Comparative Clinical Evaluation of a Novel FluA/FluB/SARS-CoV-2 Multiplex LAMP and Commercial FluA/FluB/SARS-CoV-2/RSV RT-qPCR Assays
Overview
Affiliations
Influenza and coronaviruses cause highly contagious respiratory diseases that cause millions of deaths worldwide. Public health measures implemented during the current coronavirus disease (COVID-19) pandemic have gradually reduced influenza circulation worldwide. As COVID-19 measures have relaxed, it is necessary to monitor and control seasonal influenza during this COVID-19 pandemic. In particular, the development of rapid and accurate diagnostic methods for influenza and COVID-19 is of paramount importance because both diseases have significant public health and economic impacts. To address this, we developed a multi-loop-mediated isothermal amplification (LAMP) kit capable of simultaneously detecting influenza A/B and SARS-CoV-2. The kit was optimized by testing various ratios of primer sets for influenza A/B (FluA/FluB) and SARS-CoV-2 and internal control (IC). The FluA/FluB/SARS-CoV-2 multiplex LAMP assay showed 100% specificity for uninfected clinical samples and sensitivities of 90.6%, 86.89%, and 98.96% for LAMP kits against influenza A, influenza B, and SARS-CoV-2 clinical samples, respectively. Finally, the attribute agreement analysis for clinical tests indicated substantial agreement between the multiplex FluA/FluB/SARS-CoV-2/IC LAMP and commercial Allplex SARS-CoV-2/FluA/FluB/RSV assays.
Liang Y, Xie S, Lv Y, He Y, Zheng X, Cong W Infect Dis Poverty. 2024; 13(1):94.
PMID: 39654027 PMC: 11629535. DOI: 10.1186/s40249-024-01266-5.
Enhanced Point-of-Care SARS-CoV-2 Detection: Integrating RT-LAMP with Microscanning.
Choi M, Lee E, Park S, Lim C, Jang W Biosensors (Basel). 2024; 14(7).
PMID: 39056624 PMC: 11274610. DOI: 10.3390/bios14070348.
Jang W, Lee J, Lee E, Park S, Lim C Diagnostics (Basel). 2024; 14(9).
PMID: 38732380 PMC: 11083224. DOI: 10.3390/diagnostics14090967.